Linkedin X-twitter Youtube
Launch Digital Edition

Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.

Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

Subspecialties

Interactive Product Guides

Marketplace Directory

C. diff kit earns clearance, 7/14

July 2014—Qiagen’s artus C. difficile QS-RGQ MDx Kit received FDA clearance, and its QIAsymphony RGQ MDx system was granted 510(k) regulatory clearance by the FDA. In addition, the artus VanR QS-RGQ MDx Kit for detection of vancomycin-resistant bacteria, available in Europe, is expected to be submitted to the FDA this year. The artus MRSA QS-RGQ MDx Kit for methicillin-resistant Staphylococcus aureus is expected to be launched in Europe this year and submitted to the FDA in the third quarter of 2014. Test kits for diagnosis of group B streptococcus and herpes simplex virus (HSV 1/2) are in the advanced stages of development.

FDA clearance for parathyroid hormone assay, 7/14

July 2014—DiaSorin received FDA clearance for its Liaison N-Tact PTH Gen II immunoassay, intended for the quantitative determination of intact human parathyroid hormone in human serum and plasma samples. The kit contains 200 tests and has an open-kit shelf life of 8 weeks, meeting the needs of small- and large-volume laboratories. It also has low cross-reactivity to the 7-84 and other inactive fragments, supporting conservative patient management.

New molecular methods standards, 7/14

July 2014—The Clinical and Laboratory Standards Institute released Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine; Approved Guideline—Second Edition (MM09-A2) and published a new document, Microarrays for Diagnosis and Monitoring of Infectious Diseases; Approved Guideline (MM22-A). 


Software package for data acquisition in cytometry, 7/14

July 2014—Kaluza for Gallios software for the Beckman Coulter Gallios cytometer uses data acquisition tools to increase efficiency and performance in the cell characterization and analysis workflow of core research laboratories. The software features a guided, intuitive drag-and-drop interface and facilitates creation of the right setup for accurate plot output. Visual management tools enable tracking of instrument function and experiment progress. Voltage and compensation can be quickly changed, and unlimited “undo” aids new users.

Point-of-care analyzer, 7/14

July 2014—Designed specifically for point-of-care testing, Radiometer’s ABL90 Flex is a compact, acute care analyzer with optional wireless capability, making it possible to place it near the patient and close to the OR, ED, ICU, or a step-down unit.

Leica Microsystems opens Experience Lab, 7/14

July 2014—Leica Microsystems opened an Experience Lab in its Tokyo headquarters. The laboratory is dedicated to product demonstrations of Leica microscope systems and workshops. Additionally, it serves as a showroom for microscope users who wish to get to know the instruments and accessories, such as cameras, illumination, and software. Users can bring their own samples to observe with the systems and can take advantage of a sample preparation service for industrial samples to be observed and analyzed on site.

Automated ALK FISH scanning microscope, 7/14

July 2014—BioView announced that the FDA cleared for marketing its automated scanning microscope and image analysis system, the Duet, to qualitatively detect rearrangements involving the ALK gene via fluorescence in situ hybridization in formalin-fixed, paraffin-embedded non-small cell lung cancer tissue specimens, probed with the Abbott Vysis ALK Break Apart FISH Probe Kit.

Preanalytical sample processing instrument, 7/14

July 2014—Hologic’s Tomcat instrument performs a full range of sample processing activities for liquid-based cytology samples, from decapping and capping of sample tubes to vortexing, aliquoting, incubating, and racking of each sample. The fully automated instrument provides positive bar-code matching for each sample as well as reagent addition if desired. By eliminating repetitive manual steps, the instrument enhances workflow efficiency and reduces hands-on time, which minimizes the risk of cross-contamination.

Automated slide staining system, 7/14

July 2014—Biocare Medical expanded its automated instrumentation offering with the Oncore Automated Slide Staining System. The Oncore is a compact benchtop instrument that performs both immunohistochemistry and in situ hybridization tests on formalin-fixed, paraffin-embedded tissues.

DeNovo Sciences publishes on CTC technology, 7/14

July 2014—DeNovo Sciences published “A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer.” DeNovo’s scientific team explored microfluidic capture techniques for isolating CTCs, which resulted in the development of proprietary technology to accomplish rare cell capture and analysis.

MARKETPLACE

TRENDING